Publications
Chicago HIDTA produces annual reports, threat assessments, fentanyl reports, and partner publications that highlight drug trends, enforcement outcomes, and overdose response efforts in the region.
2026
Kratom and Concentrated 7-OH: Overdose Risks and Emergency Room Visits
October 2026 briefing on kratom and concentrated 7-OH, including poison center findings, Overdose Response Strategy field data, and policy considerations.
View Brief (PDF) →2025
Chicago HIDTA 2024 Year End Summary
Overview of major initiatives, enforcement results, and program highlights for 2024.
View Report →Chicago HIDTA 2024 Fentanyl Report
Analysis of regional fentanyl trends, seizure data, and overdose patterns.
View Report →National HIDTA 2024 Perfomrance Metrics
HIDTA Program's annual performance metrics, including drug seizure data, disruption statistics for trafficking organizations, and return on investment figures.
View Report →Overdose Response Strategy 2024 Annual Report
National and regional overdose data and public health–public safety collaboration.
Open on ORS Program Site →ODMAP 2024 Annual Report
Overview of overdose mapping data and trends from the ODMAP program.
View Report →2024
Chicago HIDTA 2023 Year End Summary
Summary of 2023 enforcement, intelligence, and demand reduction activities.
View Report →Marijuana Legalization Impact Report
Assessment of the impact of marijuana legalization on trafficking, pricing, and public safety in the region.
View Report →Chicago HIDTA 2023 Fentanyl Report
Fentanyl threat assessment and analysis for 2023.
View Report →National HIDTA 2023 Perfomrance Metrics
HIDTA Program's annual performance metrics, including drug seizure data, disruption statistics for trafficking organizations, and return on investment figures.
View Report →Overdose Response Strategy 2023 Annual Report
Joint public health and public safety overdose-response partnership results.
Open on ORS Program Site →ODMAP 2023 Annual Report
Overdose mapping data and trends from ODMAP for 2023.
View Report →2023
Chicago HIDTA 2022 Year End Summary
Summary of 2022 HIDTA-supported operations, trends, and outcomes.
View Report →Chicago HIDTA 2022 Fentanyl Report
Overview of fentanyl supply, distribution patterns, and overdose trends in 2022.
View Report →National HIDTA 2022 Perfomrance Metrics
HIDTA Program's annual performance metrics, including drug seizure data, disruption statistics for trafficking organizations, and return on investment figures.
View Report →Overdose Response Strategy 2022 Annual Report
Findings and outcomes from the national ORS partnership in 2022.
Open on ORS Program Site →ODMAP 2022 Annual Report
ODMAP overdose mapping and data trends for 2022.
View Report →2022
Chicago HIDTA 2021 Year End Summary
Key activities, outcomes, and regional threat overview for 2021.
View Report →National HIDTA 2021 Perfomrance Metrics
HIDTA Program's annual performance metrics, including drug seizure data, disruption statistics for trafficking organizations, and return on investment figures.
View Report →Overdose Response Strategy 2021 Annual Report
ORS program outcomes focused on overdose prevention and response.
Open on ORS Program Site →2021
Chicago HIDTA 2020 Year End Summary
Year-end report highlighting the early-pandemic period, operations, and lessons learned.
View Report →